GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Synthetic organic
Comment: The chemical structure for envudeucitinib was obtained from proposed INN list 130 (Feb. 2024), in which the compound is described as a Janus kinase inhibitor with anti-inflammatory potential.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| N-[4-[2-methoxy-3-[1-(trideuteriomethyl)-1,2,4-triazol-3-yl]anilino]-5-(3,3,3-trideuteriopropanoyl)pyridin-2-yl]cyclopropanecarboxamide |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 12803 | envudeucitinib |
Database Links ![]() |
|
| CAS Registry No. | 2417135-66-9 (source: WHO INN record) |
| GtoPdb PubChem SID | 491299987 |
| PubChem CID | 158715582 |
| Search Google for chemical match using the InChIKey | FKCATCQHVCOBCX-WFGJKAKNSA-N |
| Search Google for chemicals with the same backbone | FKCATCQHVCOBCX |
| Search PubMed clinical trials | envudeucitinib |
| Search PubMed titles | envudeucitinib |
| Search PubMed titles/abstracts | envudeucitinib |
| UniChem Compound Search for chemical match using the InChIKey | FKCATCQHVCOBCX-WFGJKAKNSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | FKCATCQHVCOBCX-WFGJKAKNSA-N |